Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

20091,122 citationsJournal Articlebronze Open Access

Authors

Stefan H. Hohnloser · Goethe University Frankfurt

Harry J.G.M. Crijns · Maastricht University Medical Centre

Martin van Eickels · Sanofi (Mexico)

Christophe Gaudin · Sanofi (Mexico)

Richard L. Page · Seattle University

Christian Torp‐Pedersen · University of Copenhagen

Stuart J. Connolly

Abstract

Dronedarone reduced the incidence of hospitalization due to cardiovascular events or death in patients with atrial fibrillation. (ClinicalTrials.gov number, NCT00174785.)

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Imaging and Diagnostics Cardiac electrophysiology and arrhythmias

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 360, Issue 7, pp. 668-678

DOI: 10.1056/nejmoa0803778

Field-Weighted Citation Impact: 101.47